Since Alzheimer's disease affects over 7 million people in the U.S., potentially doubling to 14 million by 2050, earlier ...

Journalist and women’s health advocate Maria Shriver discusses an important new advance in the fight against Alzheimer’s ...

Low-dose interleukin-2 as an add-on therapy to riluzole (Rilutek) led to a non-significant reduction in mortality in an ...

“Exposure to herpesviruses is likely to be associated with Alzheimer’s disease and other dementia, and antiherpetic medications can be protective against Alzheimer’s and related dementia,” Liu, a ...

Treating cold sores with anti-viral medicines could help slash the risk of Alzheimer’s disease, research suggests. Previous ...

Researchers have found that the herpes virus, which causes cold sores, increases Alzheimer’s risk by as much as 80% by ...

While most people associate Alzheimer's symptoms with old age, new research suggests signs could begin to show up in your 20s ...

Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.

The Global Alzheimer's Platform Foundation® (GAP) applauds the FDA's clearance of the first blood test to diagnose ...

The Lumipulse blood test identifies the presence of amyloid plaques, a hallmark of Alzheimer’s disease that impairs normal ...

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...